Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 67 | 1 | 74 | +8 |
| Shares | 6.74M | 1.19K | 7.25M | +504.2K (+7.5%) |
| Value | $52.8M | $9.33K | $53.6M | +$856.3K (+1.6%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 141,830 | $1.05M | 0.01% |
| Squarepoint Ops LLC | 48,096 | $355.9K | 0.00% |
| Campbell & CO Investment Adviser LLC | 32,034 | $237.1K | 0.02% |
| Snowden Capital Advisors LLC | 31,344 | $231.9K | 0.01% |
| Prosperity Wealth Management, Inc. | 31,000 | $229.4K | 0.11% |
| D. E. Shaw & Co., Inc. | 29,337 | $217.1K | 0.00% |
| Corton Capital Inc. | 20,281 | $150.1K | 0.08% |
| Renaissance Technologies LLC | 19,200 | $142.1K | 0.00% |
| Corebridge Financial, Inc. | 16,174 | $119.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 14,643 | $108.4K | 0.00% |
| Alliancebernstein L.P. | 13,890 | $102.8K | 0.00% |
| Manufacturers Life Insurance Company, The | 12,488 | $92.4K | 0.00% |
| nVerses Capital, LLC | 2,200 | $16.3K | 0.01% |
| Russell Investments Group, Ltd. | 466 | $3.45K | 0.00% |
| SRS Capital Advisors, Inc. | 126 | $933 | 0.00% |
| Nisa Investment Advisors, LLC | 51 | $377 | 0.00% |
| Aviso Financial Inc. | 30 | $219 | 0.00% |
| Rothschild Investment LLC | 15 | $111 | 0.00% |
| Quest Partners LLC | 1 | $7 | 0.00% |
Sold out (11)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Hudson Bay Capital Management LP | 93,204 | $729.8K |
| Lighthouse Investment Partners, LLC | 26,408 | $206.8K |
| Group One Trading, L.P. | 22,559 | $176.6K |
| American International Group, Inc. | 13,658 | $106.9K |
| Sanders Morris Harris LLC | 10,000 | $78.3K |
| Simplex Trading, LLC | 9,071 | $71.0K |
| Qube Research & Technologies Ltd | 3,193 | $25.0K |
| Metropolitan Life Insurance Co | 1,434 | $11.2K |
| The PNC Financial Services Group, Inc. | 100 | $783 |
| Steward Partners Investment Advisory, LLC | 100 | $783 |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $39 |
Not filed for Q2 2024 yet (1)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Retirement Group, LLC | 1,191 | $9.33K |